Detailed information for compound 451040

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 318.374 | Formula: C13H10N4O2S2
  • H donors: 1 H acceptors: 2 LogP: 2.44 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1nsc2=NC(=O)/C(=C\c3ccc(cc3)O)/C(=N)n12
  • InChi: 1S/C13H10N4O2S2/c1-20-13-16-21-12-15-11(19)9(10(14)17(12)13)6-7-2-4-8(18)5-3-7/h2-6,14,18H,1H3/b9-6-,14-10?
  • InChiKey: VYODTPGNACSQJS-OAOWJTDASA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis kinesin family 1 0.085 1 1
Plasmodium falciparum kinesin-5 0.011 0.112 1
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0017 0 0.5
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.0017 0 0.5
Loa Loa (eye worm) isocitrate dehydrogenase 0.0017 0 0.0002
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0017 0 0.5
Onchocerca volvulus 0.0165 0.1771 0.5
Schistosoma mansoni kinesin eg-5 0.011 0.112 0.1291
Brugia malayi Isocitrate dehydrogenase 0.0017 0 0.0002
Loa Loa (eye worm) hypothetical protein 0.0165 0.1771 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0054 0.0446 0.2518
Schistosoma mansoni hypothetical protein 0.0037 0.0239 0.0276
Brugia malayi isocitrate dehydrogenase 0.0017 0 0.0002
Entamoeba histolytica kinesin, putative 0.011 0.112 0.5
Loa Loa (eye worm) hypothetical protein 0.0054 0.0446 0.2518
Trypanosoma brucei isocitrate dehydrogenase, putative 0.0017 0 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0054 0.0446 0.2518
Plasmodium vivax kinesin-5 0.011 0.112 1
Brugia malayi Kinesin motor domain containing protein 0.011 0.112 0.6323
Toxoplasma gondii kinesin motor domain-containing protein 0.011 0.112 1
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0017 0 0.5
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0017 0 0.5
Brugia malayi latrophilin 2 splice variant baaae 0.0037 0.0239 0.1353
Brugia malayi Calcitonin receptor-like protein seb-1 0.0054 0.0446 0.2518
Giardia lamblia Kinesin-5 0.011 0.112 0.5
Brugia malayi hypothetical protein 0.0165 0.1771 1
Schistosoma mansoni hypothetical protein 0.0739 0.8674 1
Loa Loa (eye worm) hypothetical protein 0.0037 0.0239 0.1353
Loa Loa (eye worm) kinesin-like protein KLP2 0.011 0.112 0.6323

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 72.73 % Inhibition of transthyretin amyloidosis assessed as fibril formation pH 4.4 at 100 uM ChEMBL. 17948976
Activity (functional) = 72.73 % Inhibition of transthyretin amyloidosis assessed as fibril formation pH 4.4 at 100 uM ChEMBL. 17948976
Inhibition (functional) = 27.27 % Inhibition of transthyretin fibril formation at pH 4.4 at 100 uM ChEMBL. 17948976
Inhibition (functional) = 27.27 % Inhibition of transthyretin fibril formation at pH 4.4 at 100 uM ChEMBL. 17948976

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.